Stereotactic Radiosurgery Safe for Koos Grade I Vestibular Schwannomas
By Lori Solomon HealthDay Reporter
TUESDAY, Nov. 19, 2024 -- Stereotactic radiosurgery (SRS) is safe and effective for management of Koos grade I vestibular schwannomas (VS) compared with observation, according to a study published online Nov. 6 in Neurosurgery.
Othman Bin-Alamer, M.B.B.S., from the University of Pittsburgh Medical Center, and colleagues evaluated the safety and efficacy of SRS versus observation for Koos grade I VS. The analysis included 142 patients.
During a median 36 months of follow-up, the researchers found that SRS significantly enhanced tumor control versus observation, with a 100 percent control rate at both five and eight years in the SRS group versus 48.6 and 29.5 percent in the observation group, respectively. At five and eight years, preservation of serviceable hearing outcomes between groups showed no significant differences (70.1 percent for SRS versus 53.4 percent for observation at five years). SRS was associated with a lower likelihood of tinnitus (odds ratio, 0.46), vestibular dysfunction (odds ratio, 0.17), and overall cranial nerve dysfunction (odds ratio, 0.49) at last follow-up.
"These findings support the safety and efficacy of SRS as a primary care approach for this patient population," the authors write. "Further prospective randomized studies are needed to validate these observations and delineate the superiority of SRS in this patient population."
Several authors disclosed ties to the biotechnology industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
ASCO: Durvalumab Plus FLOT Beneficial for Resectable Gastric, GE Junction Cancer
THURSDAY, June 5, 2025 -- For patients with resectable gastric or gastroesophageal junction adenocarcinoma, durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel...
Endolymphatic Sac Decompression Effective for Vertigo, Migraine
WEDNESDAY, May 28, 2025 -- For Meniere disease (MD) patients with migraine, endolymphatic sac decompression (ELSD) is effective, providing postoperative relief of vertigo and...
One-Week Radiotherapy for Breast Cancer Safe, Effective Up to 10 Years
TUESDAY, May 27, 2025 -- A five-fraction, one-week schedule of adjuvant breast radiotherapy is as safe and effective as a standard three-week schedule for patients with invasive...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.